Tenet Healthcare Corporation (THC)
- Previous Close
91.08 - Open
91.38 - Bid --
- Ask --
- Day's Range
91.36 - 93.56 - 52 Week Range
51.04 - 107.80 - Volume
1,058,028 - Avg. Volume
1,165,571 - Market Cap (intraday)
9.243B - Beta (5Y Monthly) 2.14
- PE Ratio (TTM)
16.32 - EPS (TTM)
5.71 - Earnings Date Apr 30, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Mar 13, 2000
- 1y Target Est
--
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
www.tenethealth.com78,810
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: THC
Performance Overview: THC
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: THC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: THC
Valuation Measures
Market Cap
9.24B
Enterprise Value
23.02B
Trailing P/E
16.32
Forward P/E
14.73
PEG Ratio (5yr expected)
2.04
Price/Sales (ttm)
0.48
Price/Book (mrq)
5.75
Enterprise Value/Revenue
1.12
Enterprise Value/EBITDA
6.79
Financial Highlights
Profitability and Income Statement
Profit Margin
2.97%
Return on Assets (ttm)
6.28%
Return on Equity (ttm)
25.92%
Revenue (ttm)
20.55B
Net Income Avi to Common (ttm)
611M
Diluted EPS (ttm)
5.71
Balance Sheet and Cash Flow
Total Cash (mrq)
1.23B
Total Debt/Equity (mrq)
294.35%
Levered Free Cash Flow (ttm)
893M
Research Analysis: THC
Fair Value
Analyst Recommendations
Research Reports: THC
THC: Lowering target price to $103.00
TENET HEALTHCARE CORP has an Investment Rating of HOLD; a target price of $103.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
RatingNeutralPrice TargetTHC: Lowering target price to $107.00
TENET HEALTHCARE CORP has an Investment Rating of HOLD; a target price of $107.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
RatingNeutralPrice TargetTHC: Raising target price to $108.00
TENET HEALTHCARE CORP has an Investment Rating of HOLD; a target price of $108.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
RatingNeutralPrice TargetTHC: Lowering target price to $107.00
TENET HEALTHCARE CORP has an Investment Rating of HOLD; a target price of $107.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
RatingNeutralPrice Target